These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31740626)

  • 1. Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia.
    Yang E; Cai Y; Yao X; Liu J; Wang Q; Jin W; Wu Q; Fan W; Qiu L; Kang C; Wu J
    Aging (Albany NY); 2019 Nov; 11(22):10167-10182. PubMed ID: 31740626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGFR-β restores blood-brain barrier functions in a mouse model of focal cerebral ischemia.
    Shen J; Xu G; Zhu R; Yuan J; Ishii Y; Hamashima T; Matsushima T; Yamamoto S; Takatsuru Y; Nabekura J; Sasahara M
    J Cereb Blood Flow Metab; 2019 Aug; 39(8):1501-1515. PubMed ID: 29629621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro.
    Dohgu S; Takata F; Matsumoto J; Kimura I; Yamauchi A; Kataoka Y
    Microvasc Res; 2019 Jul; 124():61-66. PubMed ID: 30885616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
    Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
    Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine Treatment Ameliorates Blood-Brain Barrier Damage After Acute Ischemic Stroke by Regulating Endothelial Scaffolding Protein Pdlim5.
    Hu X; Dong J; Geng P; Sun Y; Du W; Zhao X; Wang Q; Liu C; Wang X; Liu Y; Liu W; Cheng H; Wang W; Jin X
    Transl Stroke Res; 2024 Jun; 15(3):672-687. PubMed ID: 37233908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development.
    Chen J; Luo Y; Hui H; Cai T; Huang H; Yang F; Feng J; Zhang J; Yan X
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7622-E7631. PubMed ID: 28827364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
    Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
    Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique and shared inflammatory profiles of human brain endothelia and pericytes.
    Smyth LCD; Rustenhoven J; Park TI; Schweder P; Jansson D; Heppner PA; O'Carroll SJ; Mee EW; Faull RLM; Curtis M; Dragunow M
    J Neuroinflammation; 2018 May; 15(1):138. PubMed ID: 29751771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of common housekeeping proteins under ischemic conditions and/or rt-PA treatment in bEnd.3 cells.
    Comajoan P; Gubern C; Huguet G; Serena J; Kádár E; Castellanos M
    J Proteomics; 2018 Jul; 184():10-15. PubMed ID: 29929036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes.
    Wan Y; Jin HJ; Zhu YY; Fang Z; Mao L; He Q; Xia YP; Li M; Li Y; Chen X; Hu B
    FASEB J; 2018 Jun; 32(6):3133-3148. PubMed ID: 29401609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death.
    Kim HN; Kim TY; Yoon YH; Koh JY
    Brain Res; 2015 Dec; 1628(Pt B):317-326. PubMed ID: 26111647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
    Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL
    Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro.
    Shimizu F; Sano Y; Tominaga O; Maeda T; Abe MA; Kanda T
    Neurobiol Aging; 2013 Jul; 34(7):1902-12. PubMed ID: 23428182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in pericyte coverage leads to blood-brain barrier dysfunction via endothelial transcytosis following chronic cerebral hypoperfusion.
    Sun Z; Gao C; Gao D; Sun R; Li W; Wang F; Wang Y; Cao H; Zhou G; Zhang J; Shang J
    Fluids Barriers CNS; 2021 May; 18(1):21. PubMed ID: 33952281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.